Precision medicine and drug development based on maximising screening of limited human cancerous tissue in 3D with microfluidic technology.

ScreenIn3D

ScreenIn3D is getting ready to attend the Next Gen Organ-on-Chip & Organoids workshop organized by CSEM in Zurich on August 24-25th!

A fantastic venue to meet #clinicians, #scientists, #researchers and decision makers from the #pharma & #biotech industry and share the latest breakthroughs in #OrganOnChip.
 
We are delighted to contribute to the exciting scientific program with a talk from our CEO, Michele Zagnoni, who will be showcasing our tumour-on-a-chip platform for precision oncology. We hope to see you there at 4:50pm on day 1.
 
#OrganOnChip #Organoids #CSEM #Research #TumourOnAChip

A company specializing in microfluidic technologies for assessing CAR-T therapies in 3D complex preclinical models of solid tumors.

Microfluidic Technologies Company

A company focused on developing advanced technologies for the early detection of solid tumors.

Advanced Cancer Detection Technologies Inc.

A company employing an image-based single-cell drug screen platform with automated high content microscopy and image analysis.

Image-Based Single-Cell Drug Screen Platform Company

A company specializing in functional precision medicine, directly perturbing live tumor cells with drugs to provide personalized treatment strategies.

Functional Precision Medicine Solutions Inc.

A company focused on providing objective assessment of tumor responses and treatment results, with a key emphasis on imaging for cancer therapies.

Tumor Response Assessment Technologies LLC

Screenin3D is a company that develops microfluidic technology for cancer therapy assessment, enabling the testing of CAR-T cells and combination therapy on miniaturized solid cancer models.

Screenin3D

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 3, 2024 1:42 PM	a0bc1c99
public peers	general	May 3, 2024 1:42 PM	966b3bda
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 3, 2024 1:42 PM	b66e7d22
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 3, 2024 1:42 PM	703f809d
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 3, 2024 1:42 PM	9cf5d5bc
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:SCREENIN3D

Screenin3D